Patients News | pharmaphorum

News

Vydura is first NICE-backed oral GPCR for acute migraine

Pfizer's Vydura has become the first drug in the oral GPCR receptor antagonist class to be recommended for routine NHS use as a treatment for acute migraine.

News

Clinigen launches scheme to support rare disease patients

Clinigen has launched a new programme in the UK that aims to help organisations representing patients with rare diseases participate in R&D for new medicines and suppo

News

Eisai launches digital dementia specialist company

Eisai has been steadily building up expertise in the use of digital health systems to support people with dementia but has now gone one step further – launching a dedicate

News

CSL, BrightInsight launch Hemgenix companion app

CSL Behring's recently approved gene therapy for haemophilia B Hemgenix has joined the swelling ranks of new medicines that are bundled with a companion app to support the

News

NICE changes its mind on Lilly's Mounjaro for diabetes

Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiven

News

UK women cleared to sue Bayer over Essure contraceptive

Women in the UK who claim to have suffered harm after being fitted with Bayer's Essure contraceptive device have been cleared to pursue legal action against the company.

Vydura is first NICE-backed oral GPCR for acute migraine

Clinigen launches scheme to support rare disease patients

Eisai launches digital dementia specialist company

CSL, BrightInsight launch Hemgenix companion app

NICE changes its mind on Lilly's Mounjaro for diabetes

UK women cleared to sue Bayer over Essure contraceptive

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks